Profile picture

Professor Zoltan Papp

University of Debrecen, Debrecen (Hungary)
Membership: FESC Member HFA Member
Follow
Biography
Professor Zoltán Papp is the head of the Division of Clinical Physiology at the Faculty of Medicine, University of Debrecen, Hungary, where he also acts as vice-dean for scientific affairs. Professor Papp currently serves as secretary of the European Section of the International Society for Heart Research (ISHR-ES) and he had been chairperson of the Basic Science Section of the Heart Failure Association of the ESC (2012-2014) and had been board member of the Heart Failure Association of the ESC (2008-2014). Professor Papp’s research interests concern myocardial pathophysiology, cardiac contractility, cardiomyocyte physiology, ischemia-reperfusion injury, systolic and diastolic heart failure and myofilament targeted positive inotropic agents. He is currently Deputy Editor of ‘’ESC Heart Failure’’ (since 2014).
Logo ESC

Contributor content

Inflammation: cause or consequence of cardiovascular disease? or both?
Session
Inflammation: cause or consequence of cardiovascular disease? or both?
29 June 2021
Myocarditis: from bench to bedside
Session
Myocarditis: from bench to bedside
25 May 2019
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? – What is available?
Session
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? – What is available?
28 August 2018
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? – What is available?
Session
Inotropes or inodilators in HFrEF: what to use, on whom, when and how? – What is available?
26 August 2018
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
Session
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
28 May 2018
Moderated Poster session 4 - Basic Science
Session
Moderated Poster session 4 - Basic Science
28 May 2018
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
Session
Inotropes or inodilators in HFrEF: what to use, on whom, when and how?
27 May 2018
Inotropes or inodilators in Heart Failure with reduced Ejection Fraction (HFrEF): what to use, on whom, when and how? What is available
Session
Inotropes or inodilators in Heart Failure with reduced Ejection Fraction (HFrEF): what to use, on whom, when and how? What is available
1 May 2017
Young Investigator Award: Basic Science and Translational Science
Session
Young Investigator Award: Basic Science and Translational Science
30 April 2017
Inotropes or inodilators in Heart Failure with reduced Ejection Fraction (HFrEF): what to use, on whom, when and how? What is available
Session
Inotropes or inodilators in Heart Failure with reduced Ejection Fraction (HFrEF): what to use, on whom, when and how? What is available
30 April 2017

ESC 365 is supported by